Core Laboratories Inc. recorded a single insider purchase recently. Chairman and CEO Bruno Lawrence acquired 5,000 shares valued at $53,900 on July 31, 2026. This transaction followed an earnings report where the firm exceeded profit expectations by 37.5%. The stock price has declined 11% over the past ninety days, currently trading near its yearly low.